{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:30:07Z","timestamp":1790191807669,"version":"4.1.0"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015401","name":"Shaanxi Province Key Research and Development Projects","doi-asserted-by":"publisher","award":["2025SF-YBXM-458"],"award-info":[{"award-number":["2025SF-YBXM-458"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118299","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T14:40:57Z","timestamp":1761403257000},"page":"118299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P1","title":["Discovery of repurposed ethacrynic acid and its derivatives as novel TEAD inhibitors"],"prefix":"10.1016","volume":"302","author":[{"given":"Wei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118299_bib1","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nrc3458","article-title":"The Hippo pathway and human cancer","volume":"13","author":"Harvey","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2025.118299_bib2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.tcb.2015.05.002","article-title":"YAP and TAZ: a nexus for Hippo signaling and beyond","volume":"25","author":"Hansen","year":"2015","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejmech.2025.118299_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/dvdy.22723","article-title":"Hippo signaling in Drosophila: recent advances and insights","volume":"241","author":"Staley","year":"2011","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.ejmech.2025.118299_bib4","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cell.2013.08.025","article-title":"Spatial Organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin\/NF2","volume":"154","author":"Yin","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.118299_bib5","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1021\/acs.jmedchem.7b00879","article-title":"Targeting transcriptional enhanced associate domains (TEADs)","volume":"61","author":"Gibault","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118299_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/bies.201900162","article-title":"YAP\/TAZ: drivers of tumor growth, metastasis, and resistance to therapy","volume":"42","author":"Thompson","year":"2020","journal-title":"Bioessays"},{"key":"10.1016\/j.ejmech.2025.118299_bib7","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41568-019-0168-y","article-title":"YAP and TAZ: a signalling hub of the tumour microenvironment","volume":"19","author":"Zanconato","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2025.118299_bib8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","article-title":"EMT, CSCs, and drug resistance: the mechanistic link and clinical implications","volume":"14","author":"Shibue","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118299_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz4589","article-title":"A YAP\/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components","volume":"12","author":"Nilsson","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2025.118299_bib10","doi-asserted-by":"crossref","first-page":"114576","DOI":"10.18632\/oncotarget.23051","article-title":"YAP regulates PD-L1 expression in human NSCLC cells","volume":"8","author":"Miao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2025.118299_bib11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1158\/2326-6066.CIR-17-0320","article-title":"YAP-induced PD-L1 expression drives immune evasion in BRAFi-Resistant melanoma","volume":"6","author":"Kim","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ejmech.2025.118299_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25246001","article-title":"Protein-protein interaction disruptors of the YAP\/TAZ-TEAD transcriptional complex","volume":"25","author":"Pobbati","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118299_bib13","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.1021\/acs.jmedchem.2c00075","article-title":"Toward the design of ligands selective for the C-Terminal domain of TEADs","volume":"65","author":"Liberelle","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118299_bib14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ccr.2014.01.010","article-title":"A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer","volume":"25","author":"Jiao","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2025.118299_bib15","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1038\/s41467-017-02098-8","article-title":"Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets","volume":"8","author":"Crook","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.118299_bib16","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1021\/ml500160m","article-title":"Structure-based design and synthesis of potent cyclic peptides inhibiting the YAP-TEAD protein-protein interaction","volume":"5","author":"Zhang","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118299_bib17","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1096\/fj.14-262980","article-title":"Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides","volume":"29","author":"Zhou","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.ejmech.2025.118299_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178381","article-title":"Targeting YAP\/TAZ-TEAD protein-protein interactions using fragment-based and computational modeling approaches","volume":"12","author":"Kaan","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.118299_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113835","article-title":"Discovery of a cryptic site at the interface 2 of TEAD-Towards a new family of YAP\/TAZ-TEAD inhibitors","volume":"226","author":"Sturbaut","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118299_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106274","article-title":"Discovery of dioxo-benzo[b]thiophene derivatives as potent YAP-TEAD interaction inhibitors for treating breast cancer","volume":"131","author":"Son","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118299_bib21","article-title":"Hot spot analysis of YAP-TEAD protein-protein interaction using the fragment molecular orbital method and its application for inhibitor discovery","volume":"13","author":"Kim","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejmech.2025.118299_bib22","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s43018-024-00754-9","article-title":"Direct and selective pharmacological disruption of the YAP\u2013TEAD interface by IAG933 inhibits Hippo-dependent and RAS\u2013MAPK-altered cancers","volume":"5","author":"Chapeau","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ejmech.2025.118299_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10050140","article-title":"Toward the discovery of a novel class of YAP-TEAD interaction inhibitors by virtual screening approach targeting YAP-TEAD protein-protein interface","volume":"10","author":"Gibault","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejmech.2025.118299_bib24","article-title":"New compounds inhibitors of the Yap\/Taz-Tead interaction and their use in the treatment of malignant mesothelioma","author":"Barth","year":"2017","journal-title":"WO2017064277. Inventiva"},{"key":"10.1016\/j.ejmech.2025.118299_bib25","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1021\/acs.jmedchem.8b01402","article-title":"Antiproliferative and antimigratory effects of a novel YAP-TEAD interaction inhibitor identified using in Silico molecular docking","volume":"62","author":"Smith","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118299_bib26","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nchembio.2036","article-title":"Autopalmitoylation of TEAD proteins regulates transcriptional output of the Hippo pathway","volume":"12","author":"Chan","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118299_bib27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.str.2015.11.005","article-title":"Palmitoylation of TEAD transcription factors is required for their stability and function in Hippo Pathway signaling","volume":"24","author":"Noland Cameron","year":"2016","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2025.118299_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107809","article-title":"Small molecule dysregulation of TEAD lipidation induces a dominant-negative inhibition of Hippo Pathway signaling","volume":"31","author":"Holden","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2025.118299_bib29","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1021\/acs.jpcb.3c07073","article-title":"Allosteric modulation of the YAP\/TAZ-TEAD interaction by palmitoylation and small-molecule inhibitors","volume":"128","author":"Mills","year":"2024","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejmech.2025.118299_bib30","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.str.2015.09.009","article-title":"Targeting the central pocket in human transcription factor TEAD as a potential cancer therapeutic strategy","volume":"23","author":"Pobbati","year":"2015","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2025.118299_bib31","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.stem.2020.03.002","article-title":"Lats1\/2 sustain intestinal stem cells and Wnt activation through TEAD-Dependent and independent transcription","volume":"26","author":"Li","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ejmech.2025.118299_bib32","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1002\/cmdc.202100432","article-title":"Development of LM98, a small-molecule TEAD inhibitor derived from flufenamic acid","volume":"16","author":"Melin","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118299_bib33","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.chembiol.2018.11.010","article-title":"Small-Molecule covalent modification of Conserved cysteine leads to allosteric inhibition of the TEAD\u00b7Yap protein-protein interaction","volume":"26","author":"Bum-Erdene","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118299_bib34","first-page":"4399","article-title":"The novel potent TEAD inhibitor, K-975, inhibits YAP1\/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma","volume":"10","author":"Kaneda","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118299_bib35","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1158\/1535-7163.MCT-20-0717","article-title":"Small molecule inhibitors of TEAD auto-palmitoylation selectively inhibit proliferation and tumor growth of NF2-deficient mesothelioma","volume":"20","author":"Tang","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ejmech.2025.118299_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2023.09.680","article-title":"P2.19-01 first-in-human phase 1 trial of VT3989, a first-in-class YAP\/TEAD inhibitor in patients with advanced mesothelioma","volume":"18","author":"Yap","year":"2023","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ejmech.2025.118299_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111767","article-title":"Discovery and biological evaluation of vinylsulfonamide derivatives as highly potent, covalent TEAD autopalmitoylation inhibitors","volume":"184","author":"Lu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118299_bib38","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1016\/j.apsb.2021.04.015","article-title":"Discovery of a subtype-selective, covalent inhibitor against palmitoylation pocket of TEAD3","volume":"11","author":"Lu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.118299_bib39","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ccell.2019.12.006","article-title":"Treatment-Induced Tumor dormancy through YAP-mediated transcriptional reprogramming of the apoptotic pathway","volume":"37","author":"Kurppa","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2025.118299_bib40","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.78810","article-title":"Covalent disruptor of YAP-TEAD association suppresses defective Hippo signaling","volume":"11","author":"Fan","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.ejmech.2025.118299_bib41","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1021\/acs.jmedchem.2c01548","article-title":"Structure-based design of Y-Shaped covalent TEAD inhibitors","volume":"66","author":"Lu","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118299_bib42","doi-asserted-by":"crossref","first-page":"9206","DOI":"10.1021\/acs.jmedchem.2c00403","article-title":"Optimization of TEAD P-Site binding fragment hit into in vivo active lead MSC-4106","volume":"65","author":"Heinrich","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118299_bib43","article-title":"Discovery of a new class of reversible TEA domain transcription factor inhibitors with a novel binding mode","volume":"11","author":"Liu","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.ejmech.2025.118299_bib44","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1021\/acs.jmedchem.4c02884","article-title":"Selective degradation of TEADs by a PROTAC molecule exhibited robust anticancer efficacy in vitro and in vivo","volume":"68","author":"Lu","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118299_bib45","doi-asserted-by":"crossref","first-page":"LB238","DOI":"10.1158\/1538-7445.AM2025-LB238","article-title":"Abstract LB238: expanding the TEAD therapeutic potential with degraders: in vitro sensitivity, predictive biomarkers, and in vivo efficacy","volume":"85","author":"Sawant","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118299_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202503277","article-title":"Discovery of a potent and selective TEAD degrader with durable degradation activity","author":"Cao","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejmech.2025.118299_bib47","doi-asserted-by":"crossref","first-page":"LB438","DOI":"10.1158\/1538-7445.AM2025-LB438","article-title":"Abstract LB438: discovery of a potent and selective pan-TEAD PROTAC directly targeting TEAD-YAP interaction with durable degradation activity","volume":"85","author":"Zhao","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118299_bib48","article-title":"Targeted degradation of specific TEAD paralogs by small molecule degraders","volume":"10","author":"Chen","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ejmech.2025.118299_bib49","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1021\/acsmedchemlett.4c00029","article-title":"Design, synthesis, and bioevaluation of transcriptional enhanced assocciated domain (TEAD) PROTAC degraders","volume":"15","author":"Li","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118299_bib50","series-title":"Amphista Therapeutics Discloses First Details of its TEAD Targeted Glue\u2122 Program and Unveils New Mechanism of Action for TEAD Degradation via FBXO22","year":"2025"},{"key":"10.1016\/j.ejmech.2025.118299_bib51","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.trecan.2024.10.004","article-title":"Targeting the Hippo pathway in cancer: kidney toxicity as a class effect of TEAD inhibitors?","volume":"11","author":"Paul","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ejmech.2025.118299_bib52","doi-asserted-by":"crossref","first-page":"LB428","DOI":"10.1158\/1538-7445.AM2024-LB428","article-title":"Abstract LB428: discovery of KY-001:A direct inhibitor of TEAD-YAP protein-protein interaction for the treatment of advanced solid tumors with abnormal hippo signaling pathway","volume":"84","author":"Zhao","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118299_bib53","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1158\/1538-7445.AM2024-4585","article-title":"Abstract 4585: discovery of ETS-006, a highly potent YAP\/TEADs PPI inhibitor with broad anti-tumor activity as a single agent","volume":"84","author":"Lu","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118299_bib54","doi-asserted-by":"crossref","first-page":"7082","DOI":"10.1021\/ja311416v","article-title":"2-Bromopalmitate analogues as activity-based probes to explore palmitoyl acyltransferases","volume":"135","author":"Zheng","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.118299_bib55","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1158\/0008-5472.CAN-10-2711","article-title":"Taxol resistance in breast cancer cells is mediated by the Hippo Pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF","volume":"71","author":"Lai","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118299_bib56","article-title":"Ethacrynic acid: a promising candidate for drug repurposing as an anticancer agent","volume":"24","author":"Yu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118299_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.732922","article-title":"Loop diuretics inhibit ischemia-induced intracellular Ca2+ overload in neurons via the inhibition of voltage-gated Ca2+ and Na+ channels","volume":"12","author":"Katnik","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118299_bib58","article-title":"Ethacrynic acid exhibits selective toxicity to chronic lymphocytic leukemia cells by inhibition of the Wnt\/\u03b2-Catenin pathway","volume":"4","author":"Williams","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.118299_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/cancers8070066","article-title":"A second WNT for old drugs: drug repositioning against WNT-dependent cancers","volume":"8","author":"Ahmed","year":"2016","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2025.118299_bib60","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/01.shk.0000150629.53699.3f","article-title":"Ethacrynic acid inhibits multiple steps in the NF-\u03baB signaling pathway","volume":"23","author":"Han","year":"2005","journal-title":"Shock"},{"key":"10.1016\/j.ejmech.2025.118299_bib61","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1165\/rcmb.2013-0544OC","article-title":"The compromise of macrophage functions by hyperoxia is attenuated by ethacrynic acid via inhibition of NF-\u03baB\u2013Mediated release of high-mobility group Box-1","volume":"52","author":"Wang","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.118299_bib62","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/j.1349-7006.2003.tb01371.x","article-title":"Characterization of cell death induced by ethacrynic acid in a human colon cancer cell line DLD\u20101 and suppression by N\u2010acetyl\u2010l\u2010cysteine","volume":"94","author":"Aizawa","year":"2005","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ejmech.2025.118299_bib63","doi-asserted-by":"crossref","first-page":"21631","DOI":"10.18632\/oncotarget.7795","article-title":"High LEF1 expression predicts adverse prognosis in chronic lymphocytic leukemia and may be targeted by ethacrynic acid","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2025.118299_bib64","first-page":"175","article-title":"Ethacrynic acid inhibits STAT3 activity through the modulation of SHP2 and PTP1B tyrosine phosphatases in DU145 prostate carcinoma cells","author":"Lee","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118299_bib65","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.bbrc.2013.04.044","article-title":"Menadione and ethacrynic acid inhibit the hypoxia-inducible factor (HIF) pathway by disrupting HIF-1\u03b1 interaction with p300","volume":"434","author":"Na","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2025.118299_bib66","doi-asserted-by":"crossref","first-page":"58038","DOI":"10.18632\/oncotarget.10846","article-title":"Ethacrynic acid improves the antitumor effects of irreversible epidermal growth factor receptor tyrosine kinase inhibitors in breast cancer","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2025.118299_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/celldisc.2016.31","article-title":"Decreased glutathione biosynthesis contributes to EGFR T790M-driven erlotinib resistance in non-small cell lung cancer","volume":"2","author":"Li","year":"2016","journal-title":"Cell Discovery"},{"key":"10.1016\/j.ejmech.2025.118299_bib68","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1038\/sj.onc.1206940","article-title":"The role of glutathione-S-transferase in anti-cancer drug resistance","volume":"22","author":"Townsend","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2025.118299_bib69","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.biopha.2012.10.011","article-title":"6r, a novel oxadiazole analogue of ethacrynic acid, exhibits antitumor activity both in vitro and in vivo by induction of cell apoptosis and S-phase arrest","volume":"67","author":"Zhang","year":"2013","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.118299_bib70","doi-asserted-by":"crossref","DOI":"10.4172\/2161-0444.1000511","article-title":"Encouraging effects of ethacrynic acid derivatives possessing a privileged \u03b1, \u03b2-Unsaturated carbonyl structure scaffold","volume":"8","author":"Dong","year":"2018","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118299_bib71","first-page":"915","article-title":"Reversible conjugation of ethacrynic acid with glutathione and human glutathione S-transferase P1-1","volume":"54","author":"Ploemen","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118299_bib72","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0014-5793(98)01546-4","article-title":"GSTP1\u20101 stereospecifically catalyzes glutathione conjugation of ethacrynic acid","volume":"441","author":"van Iersel","year":"1998","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"key":"10.1016\/j.ejmech.2025.118299_bib73","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S1359-6446(05)03610-X","article-title":"Measurements of binding thermodynamics in drug discovery","volume":"10","author":"Holdgate","year":"2005","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2025.118299_bib74","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-biophys-070816-033743","article-title":"The molecular origin of Enthalpy\/Entropy compensation in biomolecular recognition","volume":"47","author":"Fox","year":"2018","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.ejmech.2025.118299_bib75","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1038\/nprot.2007.321","article-title":"The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability","volume":"2","author":"Niesen","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejmech.2025.118299_bib76","article-title":"Novel chemical ligands to Ebola virus and Marburg Virus nucleoproteins identified by combining affinity Mass spectrometry and metabolomics approaches","volume":"6","author":"Fu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118299_bib77","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1021\/jacsau.3c00684","article-title":"Mechanistic insights into dibasic iminosugars as pH-Selective pharmacological chaperones to stabilize Human \u03b1-Galactosidase","volume":"4","author":"Li","year":"2024","journal-title":"JACS Au"},{"key":"10.1016\/j.ejmech.2025.118299_bib78","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1021\/acschembio.9b00786","article-title":"Identification of quinolinols as activators of TEAD-Dependent transcription","volume":"14","author":"Pobbati","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118299_bib79","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1021\/acsmedchemlett.3c00386","article-title":"Development of HC-258, a covalent acrylamide TEAD inhibitor that reduces gene expression and cell migration","volume":"14","author":"Fnaiche","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118299_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10040090","article-title":"Targeting the hippo pathway is a new potential therapeutic modality for malignant mesothelioma","volume":"10","author":"Sekido","year":"2018","journal-title":"Cancers."},{"key":"10.1016\/j.ejmech.2025.118299_bib81","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/0006-2952(85)90411-3","article-title":"Inhibition of purified rat liver glutathione S-transferase isozymes by diuretic drugs","volume":"34","author":"Ahokas","year":"1985","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118299_bib82","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.devcel.2010.03.007","article-title":"The Hippo pathway regulates Wnt\/\u03b2-Catenin signaling","volume":"18","author":"Varelas","year":"2010","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ejmech.2025.118299_bib83","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-0302-x","article-title":"EGFR-PI3K-PDK1 pathway regulates YAP signaling in hepatocellular carcinoma: the mechanism and its implications in targeted therapy","volume":"9","author":"Xia","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2025.118299_bib84","article-title":"The Hippo effector YAP regulates the response of cancer cells to MAPK pathway inhibitors","volume":"3","author":"Lin","year":"2015","journal-title":"Molecular & Cellular Oncology"},{"key":"10.1016\/j.ejmech.2025.118299_bib85","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1073\/pnas.1216462110","article-title":"Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1","volume":"110","author":"Fan","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejmech.2025.118299_bib86","doi-asserted-by":"crossref","first-page":"462","DOI":"10.15252\/embj.201592081","article-title":"Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP\/TAZ activation","volume":"35","author":"Kim","year":"2015","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2025.118299_bib87","doi-asserted-by":"crossref","first-page":"51922","DOI":"10.18632\/oncotarget.10458","article-title":"YAP promotes erlotinib resistance in human non-small cell lung cancer cells","volume":"7","author":"Hsu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2025.118299_bib88","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s00018-016-2412-x","article-title":"Role of YAP\/TAZ transcriptional regulators in resistance to anti-cancer therapies","volume":"74","author":"Kim","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2025.118299_bib89","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.trecan.2019.02.010","article-title":"YAP\/TAZ signaling and resistance to cancer therapy","volume":"5","author":"Nguyen","year":"2019","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ejmech.2025.118299_bib90","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/cam4.2668","article-title":"YAP1 promotes multidrug resistance of small cell lung cancer by CD74\u2010related signaling pathways","volume":"9","author":"Song","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.ejmech.2025.118299_bib91","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1158\/1078-0432.CCR-19-4179","article-title":"Yap1 mediates trametinib resistance in head and neck squamous cell carcinomas","volume":"27","author":"Mudianto","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118299_bib92","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.molcel.2021.01.010","article-title":"Interferon-\u03b3 induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation","volume":"81","author":"Yu","year":"2021","journal-title":"Mol Cell"},{"key":"10.1016\/j.ejmech.2025.118299_bib93","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1158\/2159-8290.CD-17-1124","article-title":"YAP is essential for treg-mediated suppression of Antitumor immunity","volume":"8","author":"Ni","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejmech.2025.118299_bib94","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/nprot.2014.138","article-title":"The cellular thermal shift assay for evaluating drug target interactions in cells","volume":"9","author":"Jafari","year":"2014","journal-title":"Nat. Protoc."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425010645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425010645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:45:50Z","timestamp":1773276350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425010645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":94,"alternative-id":["S0223523425010645"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118299","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of repurposed ethacrynic acid and its derivatives as novel TEAD inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118299","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118299"}}